Personalized Risk Model for Predicting Risk of Acute Coronary Syndrome in Patients with Myelodysplastic Syndromes
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes.
Adrianzen-Herrera D, Strumlowska A Curr Hematol Malig Rep. 2025; 20(1):6.
PMID: 39821758 DOI: 10.1007/s11899-025-00750-5.
References
1.
Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S
. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87.
PMC: 4290021.
DOI: 10.1056/NEJMoa1409405.
View
2.
Nachtkamp K, Stark R, Strupp C, Kundgen A, Giagounidis A, Aul C
. Causes of death in 2877 patients with myelodysplastic syndromes. Ann Hematol. 2016; 95(6):937-44.
DOI: 10.1007/s00277-016-2649-3.
View
3.
Falantes J, Marquez-Malaver F, Knight T, Calderon-Cabrera C, Martino M, Gonzalez J
. The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome. Leuk Lymphoma. 2016; 58(8):1893-1902.
DOI: 10.1080/10428194.2016.1267350.
View
4.
Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D
. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651.
DOI: 10.1161/CIR.0000000000000617.
View
5.
Ma X
. Epidemiology of myelodysplastic syndromes. Am J Med. 2012; 125(7 Suppl):S2-5.
PMC: 3394456.
DOI: 10.1016/j.amjmed.2012.04.014.
View